Latest
- Metals & Mining
Critical-Minerals Surge: Mining Industry Flags Big Shift at IMARC 2025...
The spotlight at this year’s IMARC 2025 in Sydney has crystallised around a clear message for investors: the era of passive optimism in critical‐minerals is…
- Technology
Interactive Brokers Rolls Out AI Assistant for Portfolios...
AI Steps Deeper Into Finance as Interactive Brokers Launches Portfolio Assistant In a fresh demonstration of artificial intelligence’s growing foothold in financial services, Interactive…
- Markets
Major Indices Slip on China-Tech Export Fears and Earnings Headwinds...
Markets Take a Cautious Turn as Trade Jitters Resurface Global equity markets stumbled on Thursday as renewed concerns over U.S.–China technology trade tensions and…
- Emerging Industries
$1.8 Billion Critical-Minerals Consortium Enters Supply-Chain War...
Global supply chains for critical minerals—lithium, nickel, cobalt, and rare earths—are entering a new battleground as a $1.8 billion consortium led by Orion Resource…
- Cryptocurrency
Ethereum-Linked Staking Firm Launches Game-Changing Program...
The Next Evolution in Ethereum Staking In a move that’s sending ripples through the decentralized finance (DeFi) landscape, Cryptomesh, a blockchain staking specialist, has…
- Artificial Intelligence
AI Infrastructure Surge: Satellite & Comm Firms Ride the Build-OutBy...
The Next Wave of AI Infrastructure: Beyond Chips As the global race to build out artificial intelligence (AI) infrastructure accelerates, attention is shifting away…
- Technology
CardiolRx’s (NASDAQ:CRDL) ARCHER Trial Marks a Milestone in Acute Myocarditis...
Key Highlights: ARCHER Phase II Trial Design and Topline Results Cardiol Therapeutics’ ARCHER trial was a multi-national, randomized, double-blind, placebo-controlled Phase II study evaluating…
Must Read